Biogen idec received approval to market its hemophilia b treatment alprolix in the united states. In this clip from the motley fool s industry focus. View biogens fda inspection, warning letter, form 483 observation details related to gmp quality systems on. Robust pipeline late, early, discovery product pipeline significantly. The roche group maintains sole responsibility for the development, manufacturing and commercialization of obinutuzumab in the u. Biogen idecs business fundamentals are strong and we are building on. Biogen idec has a strong platform of products, pipeline and financial. Michel vounatsos, chief executive officer at biogen, discusses his companys new drug pipeline and efforts to control drug pricing for consumers. Information provided on this web page is aggregated encyclopedic and bibliographical information relating to the named institution. Nasdaq gs including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Biogen ceo vounatsos on drug pipeline, pricing bloomberg. Biogen, idec is a merger of portfolio equals, too thestreet. We are prioritizing our resources on what we believe are the most promising programs. Biogen idec to expand oncology pipeline with acquisition of conforma. Biogen idec provides business update at investor meeting biogen. There was concern about adverse reactions, including deaths from pml, from. Biogen idec collaborates on obinutuzumab with genentech, a wholly owned subsidiary of roche pharmaceuticals.
It will make the product in its facilities in the triangle. We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. This information is intended only for residents of canada. Biogen idec to expand oncology pipeline with acquisition. Biogen has pioneered the development of multiple sclerosis ms treatments for more than 25 years. The fda approves obinutuzumab for chronic lymphocytic leukemia cll. Information provided is not approved by the institution itself. The companys product pipeline includes 15 products in phase 2 and beyond, and. Biogen idec ceo talks drugs in pipeline, keys to growth. Biogen idec picks up neurimmunes neurodegenerative programs. Biogens alzheimers hope tops the sectors most valuable. Biogen and sangamo announce global collaboration to develop gene regulation therapies for alzheimers, parkinsons, neuromuscular, and other neurological diseases. Biogen announces agreement to acquire nightstar therapeutics to. In 2019, the companys top product tecfidera generated.
By continuing to browse the site you are agreeing to our policy on the use of cookies. Based on expected growth from the combined product lineup, the contribution of pipeline products, and. Nasdaq gs stock quote biogen inc bloomberg markets. Isis pharmaceuticals and biogen idec with antisense currently in.
Despite an exciting pipeline and some smart and dedicated employees, biogen is plagued by internal politics and favoritism. Biogen idec features data on avonexr and tysabrir and. Our pipeline is more than a list of medicines in development. Alexander served as general counsel of iona technologies, a software company. We continue to innovate to advance ms treatment and improve outcomes for patients. Status indication names phase trial name identification. On october 22, 2019, biogen announced that, after consulting with the u. Is it telling of some frothiness in the market that the industrys most valuable latestage asset is thought to be. Update on the spinal muscular atrophy drug development pipeline. The blockbuster potential of biogen incs pipeline the.
Biogen has a strong late stage pipeline with the potential to launch new products for multiple sclerosis, amyotrophic lateral sclerosis als and hemophilia by. For 30 years, biogen idec has been transforming discoveries into. After the merger, biogen idec became the 3rd largest biotechnology company in the. The blockbuster potential of biogen incs pipeline blue chip biotech stock biogen has a strong pipeline full of drugs that could offer multi billion dollar opportunity. It reflects the work we do here every day to break new ground with science that makes a difference. For product information for other countries, please visit your countrys biogen affiliate website. Hemoglobinopathies market is expected to cross usd 14. Biogen top products based on revenue 20162019 statista. The patent will hold off the entry of generic competition longer than previously anticipated. Biogen shared phase 3 topline data on our investigational therapy for early alzheimers disease at the 12th clinical trials on alzheimers disease ctad conference. Biogen idec picks up neurimmunes neurodegenerative programs for. Please find updates on biogens response to covid19 here. While it is difficult to predict 100% pipeline success, we believe that biogen idec has established a strong track record for pipeline development and believe that more programs will succeed.
Biogen idec nabs fda approval for hemophilia product. Since our founding in 1978 as one of the worlds first global biotechnology companies, biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Biogen idec celebrates 30 years of transforming discovery into care. Our research is focused on potentially transformative therapies, including the potential repair of the damage caused by ms. Biogen idec product pipeline will propel it higher.
482 1495 513 1625 827 539 772 534 553 1015 1204 927 52 414 19 886 379 223 900 4 1496 868 1465 385 764 1432 128 954 1174 512 700 475 963 425 598 569 213 250